✦ LIBER ✦

Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy

✍ Scribed by Hans Heemskerk; Christa L. de Winter; Gert-Jan B. van Ommen; Judith C.T. van Deutekom; Annemieke Aartsma-Rus

Book ID: 111399372
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 359 KB
Volume: 1175
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.2009.04973.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Theoretic applicability of antisense-med

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

✍ Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van De 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Antisense-mediated exon skipping aiming for reading frame restoration is currently a promising therapeutic application for Duchenne muscular dystrophy (DMD). This approach is mutation specific, but as the majority of DMD patients have deletions that cluster in hotspot regions, the skipping of a smal

In vivo comparison of 2′-O-methyl phosph

In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

✍ Hans A. Heemskerk; Christa L. de Winter; Sjef J. de Kimpe; Petra van Kuik-Romeij 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

## Abstract ## Background Antisense‐mediated exon skipping is a putative treatment for Duchenne muscular dystrophy (DMD). Using antisense oligonucleotides (AONs), the disrupted DMD reading frame is restored, allowing generation of partially functional dystrophin and conversion of a severe Duchenne

In vitro evaluation of novel antisense o

In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy

✍ Qingsong Wang; HaiFang Yin; Patrizia Camelliti; Corinne Betts; Hong Moulton; Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

## Abstract ## Background Targeted splice modulation of pre‐mRNA transcripts by antisense oligonucleotides (AOs) can correct the function of aberrant disease‐related genes. Duchenne muscular dystrophy (DMD) arises as a result of mutations that interrupt the open‐reading frame in the DMD gene encod

Exon-skipped dystrophins for treatment o

Exon-skipped dystrophins for treatment of Duchenne muscular dystrophy: Mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics

✍ Christine Carag Krieger; Nishant Bhasin; Manorama Tewari; Andre E. X. Brown; Dan 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 842 KB

Exon skipping and reading through stop c

Exon skipping and reading through stop codons: two research approaches for a therapy of Duchenne muscular dystrophy. Monaco, 17–18 January, 2004

✍ Guenter Scheuerbrandt 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Exon skipping to change Duchenne into Becker dystrophy The exon-skipping technique tries to change a Duchenne into a Becker mutation. If a deletion or a point mutation disturbs the reading frame, and thus causes Duchenne dystrophy, the reading frame can be restored by removing one or more exons

Characterization of a complex Duchenne m

Characterization of a complex Duchenne muscular dystrophy–causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping

✍ Heidi R. Madden; Sue Fletcher; Mark R. Davis; Steve D. Wilton 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Out of three mutations in the dystrophin gene that cause Duchenne muscular dystrophy (DMD), the most common, serious childhood muscle wasting disease, two are genomic deletions of one or more exons that disrupt the reading frame. Specific removal of an exon flanking a genomic deletion using antisens